Biguanide-transition metals complexes as potential drug for hyperglycemia treatment
ABSTRACT: Coordination compounds of Cu(ii), Ni(ii), Co(ii), and Zn(ii) with a type of biguanide (known commercially as metformin) have been synthesized and characterized using spectroscopic techniques (FT-IR, UV/VIS), X-ray diffraction techniques and thermal analysis. For all compounds, single cryst...
- Autores:
-
Balcázar Morales, Norman
Villamizar Delgado, Stephanny
Porras Osorio, Laura M.
Piñeros, Octavio
Ellena, Javier
Varela Miranda, Rubén E.
D'Vries, Richard F.
- Tipo de recurso:
- Article of investigation
- Fecha de publicación:
- 2020
- Institución:
- Universidad de Antioquia
- Repositorio:
- Repositorio UdeA
- Idioma:
- eng
- OAI Identifier:
- oai:bibliotecadigital.udea.edu.co:10495/41104
- Acceso en línea:
- https://hdl.handle.net/10495/41104
- Palabra clave:
- Hiperglucemia
Hyperglycemia
Biguanidas
Biguanides
Metformina
Metformin
https://id.nlm.nih.gov/mesh/D006943
https://id.nlm.nih.gov/mesh/D001645
https://id.nlm.nih.gov/mesh/D008687
- Rights
- openAccess
- License
- https://creativecommons.org/licenses/by-nc/4.0/
| id |
UDEA2_c0d637c41dea417990576d283d43d2d4 |
|---|---|
| oai_identifier_str |
oai:bibliotecadigital.udea.edu.co:10495/41104 |
| network_acronym_str |
UDEA2 |
| network_name_str |
Repositorio UdeA |
| repository_id_str |
|
| dc.title.spa.fl_str_mv |
Biguanide-transition metals complexes as potential drug for hyperglycemia treatment |
| title |
Biguanide-transition metals complexes as potential drug for hyperglycemia treatment |
| spellingShingle |
Biguanide-transition metals complexes as potential drug for hyperglycemia treatment Hiperglucemia Hyperglycemia Biguanidas Biguanides Metformina Metformin https://id.nlm.nih.gov/mesh/D006943 https://id.nlm.nih.gov/mesh/D001645 https://id.nlm.nih.gov/mesh/D008687 |
| title_short |
Biguanide-transition metals complexes as potential drug for hyperglycemia treatment |
| title_full |
Biguanide-transition metals complexes as potential drug for hyperglycemia treatment |
| title_fullStr |
Biguanide-transition metals complexes as potential drug for hyperglycemia treatment |
| title_full_unstemmed |
Biguanide-transition metals complexes as potential drug for hyperglycemia treatment |
| title_sort |
Biguanide-transition metals complexes as potential drug for hyperglycemia treatment |
| dc.creator.fl_str_mv |
Balcázar Morales, Norman Villamizar Delgado, Stephanny Porras Osorio, Laura M. Piñeros, Octavio Ellena, Javier Varela Miranda, Rubén E. D'Vries, Richard F. |
| dc.contributor.author.none.fl_str_mv |
Balcázar Morales, Norman Villamizar Delgado, Stephanny Porras Osorio, Laura M. Piñeros, Octavio Ellena, Javier Varela Miranda, Rubén E. D'Vries, Richard F. |
| dc.contributor.researchgroup.spa.fl_str_mv |
Genética Molecular (GENMOL) |
| dc.subject.decs.none.fl_str_mv |
Hiperglucemia Hyperglycemia Biguanidas Biguanides Metformina Metformin |
| topic |
Hiperglucemia Hyperglycemia Biguanidas Biguanides Metformina Metformin https://id.nlm.nih.gov/mesh/D006943 https://id.nlm.nih.gov/mesh/D001645 https://id.nlm.nih.gov/mesh/D008687 |
| dc.subject.meshuri.none.fl_str_mv |
https://id.nlm.nih.gov/mesh/D006943 https://id.nlm.nih.gov/mesh/D001645 https://id.nlm.nih.gov/mesh/D008687 |
| description |
ABSTRACT: Coordination compounds of Cu(ii), Ni(ii), Co(ii), and Zn(ii) with a type of biguanide (known commercially as metformin) have been synthesized and characterized using spectroscopic techniques (FT-IR, UV/VIS), X-ray diffraction techniques and thermal analysis. For all compounds, single crystals were obtained for single-crystal X-ray diffraction. For the first time, an octahedral cobalt compound with the formula [Co(C4H11N5)3]Cl2·2H2O that crystallizes in the monoclinic space group C2/c with one molecule in the asymmetric unit has been obtained. Also, a novel nickel compound with the formula [Ni(C4H11N5) (C4H10N5)]Cl·H2O that crystallizes in the monoclinic space group P21/c with two molecules in the asymmetric unit was obtained. Finally, we obtained copper and zinc compounds that crystallize in the monoclinic space groups P21/n and P21/c with the general formula [Cu(C4H11N5)2]Cl2·H2O and [Zn(C4H12N5)Cl3], respectively. A structural and supramolecular analysis was developed for all compounds using Hirshfeld surface analysis and electrostatic potential maps. The cell viability of the obtained compounds was evaluated in C2C12 (ATCCCRL-1772™) mouse muscle cells and HepG2 (ATCC HB-8065™) human liver carcinoma cells by the MTT assay to determine the potential of the compounds as new safe drugs. The results demonstrate that the compounds exhibit low cytotoxicity at doses less than 250 μg mL-1 with a cell viability greater than 80%. |
| publishDate |
2020 |
| dc.date.issued.none.fl_str_mv |
2020 |
| dc.date.accessioned.none.fl_str_mv |
2024-08-12T01:09:44Z |
| dc.date.available.none.fl_str_mv |
2024-08-12T01:09:44Z |
| dc.type.spa.fl_str_mv |
Artículo de investigación |
| dc.type.coar.spa.fl_str_mv |
http://purl.org/coar/resource_type/c_2df8fbb1 |
| dc.type.redcol.spa.fl_str_mv |
https://purl.org/redcol/resource_type/ART |
| dc.type.coarversion.spa.fl_str_mv |
http://purl.org/coar/version/c_970fb48d4fbd8a85 |
| dc.type.driver.spa.fl_str_mv |
info:eu-repo/semantics/article |
| dc.type.version.spa.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
| format |
http://purl.org/coar/resource_type/c_2df8fbb1 |
| status_str |
publishedVersion |
| dc.identifier.citation.spa.fl_str_mv |
Villamizar-Delgado S, Porras-Osorio LM, Piñeros O, Ellena J, Balcazar N, Varela-Miranda RE, D'Vries RF. Biguanide-transition metals complexes as potential drug for hyperglycemia treatment. RSC Adv. 2020 Jun 16;10(38):22856-22863. doi: 10.1039/d0ra04059b. PMID: 35514600; PMCID: PMC9054726. |
| dc.identifier.uri.none.fl_str_mv |
https://hdl.handle.net/10495/41104 |
| dc.identifier.doi.none.fl_str_mv |
10.1039/d0ra04059b |
| dc.identifier.eissn.none.fl_str_mv |
2046-2069 |
| identifier_str_mv |
Villamizar-Delgado S, Porras-Osorio LM, Piñeros O, Ellena J, Balcazar N, Varela-Miranda RE, D'Vries RF. Biguanide-transition metals complexes as potential drug for hyperglycemia treatment. RSC Adv. 2020 Jun 16;10(38):22856-22863. doi: 10.1039/d0ra04059b. PMID: 35514600; PMCID: PMC9054726. 10.1039/d0ra04059b 2046-2069 |
| url |
https://hdl.handle.net/10495/41104 |
| dc.language.iso.spa.fl_str_mv |
eng |
| language |
eng |
| dc.relation.ispartofjournalabbrev.spa.fl_str_mv |
RSC. Adv. |
| dc.relation.citationendpage.spa.fl_str_mv |
22863 |
| dc.relation.citationissue.spa.fl_str_mv |
38 |
| dc.relation.citationstartpage.spa.fl_str_mv |
22856 |
| dc.relation.citationvolume.spa.fl_str_mv |
10 |
| dc.relation.ispartofjournal.spa.fl_str_mv |
RSC Advances |
| dc.rights.uri.spa.fl_str_mv |
https://creativecommons.org/licenses/by-nc/4.0/ |
| dc.rights.uri.*.fl_str_mv |
http://creativecommons.org/licenses/by-nc/2.5/co/ |
| dc.rights.accessrights.spa.fl_str_mv |
info:eu-repo/semantics/openAccess |
| dc.rights.coar.spa.fl_str_mv |
http://purl.org/coar/access_right/c_abf2 |
| rights_invalid_str_mv |
https://creativecommons.org/licenses/by-nc/4.0/ http://creativecommons.org/licenses/by-nc/2.5/co/ http://purl.org/coar/access_right/c_abf2 |
| eu_rights_str_mv |
openAccess |
| dc.format.extent.spa.fl_str_mv |
8 páginas |
| dc.format.mimetype.spa.fl_str_mv |
application/pdf |
| dc.publisher.spa.fl_str_mv |
Royal Society of Chemistry |
| dc.publisher.place.spa.fl_str_mv |
Cambridge, Inglaterra |
| institution |
Universidad de Antioquia |
| bitstream.url.fl_str_mv |
https://bibliotecadigital.udea.edu.co/bitstreams/196a1f72-41d7-4bd9-adb3-6c0c8643a991/download https://bibliotecadigital.udea.edu.co/bitstreams/8d93dab4-2987-4e75-8dc8-301b0ed9352c/download https://bibliotecadigital.udea.edu.co/bitstreams/72eec5f3-36c3-45fa-b693-9f60543fa84b/download https://bibliotecadigital.udea.edu.co/bitstreams/794edbb9-d7ef-4413-9e55-f3b0d71aef77/download |
| bitstream.checksum.fl_str_mv |
44b3aba3bfaa73fd0205fc4810c27a88 8a4605be74aa9ea9d79846c1fba20a33 b0d135122b1c45916bb643f0fedd8fc3 35dfd708ca9b3899bb6c5a7c364fc1af |
| bitstream.checksumAlgorithm.fl_str_mv |
MD5 MD5 MD5 MD5 |
| repository.name.fl_str_mv |
Repositorio Institucional de la Universidad de Antioquia |
| repository.mail.fl_str_mv |
aplicacionbibliotecadigitalbiblioteca@udea.edu.co |
| _version_ |
1851052641109409792 |
| spelling |
Balcázar Morales, NormanVillamizar Delgado, StephannyPorras Osorio, Laura M.Piñeros, OctavioEllena, JavierVarela Miranda, Rubén E.D'Vries, Richard F.Genética Molecular (GENMOL)2024-08-12T01:09:44Z2024-08-12T01:09:44Z2020Villamizar-Delgado S, Porras-Osorio LM, Piñeros O, Ellena J, Balcazar N, Varela-Miranda RE, D'Vries RF. Biguanide-transition metals complexes as potential drug for hyperglycemia treatment. RSC Adv. 2020 Jun 16;10(38):22856-22863. doi: 10.1039/d0ra04059b. PMID: 35514600; PMCID: PMC9054726.https://hdl.handle.net/10495/4110410.1039/d0ra04059b2046-2069ABSTRACT: Coordination compounds of Cu(ii), Ni(ii), Co(ii), and Zn(ii) with a type of biguanide (known commercially as metformin) have been synthesized and characterized using spectroscopic techniques (FT-IR, UV/VIS), X-ray diffraction techniques and thermal analysis. For all compounds, single crystals were obtained for single-crystal X-ray diffraction. For the first time, an octahedral cobalt compound with the formula [Co(C4H11N5)3]Cl2·2H2O that crystallizes in the monoclinic space group C2/c with one molecule in the asymmetric unit has been obtained. Also, a novel nickel compound with the formula [Ni(C4H11N5) (C4H10N5)]Cl·H2O that crystallizes in the monoclinic space group P21/c with two molecules in the asymmetric unit was obtained. Finally, we obtained copper and zinc compounds that crystallize in the monoclinic space groups P21/n and P21/c with the general formula [Cu(C4H11N5)2]Cl2·H2O and [Zn(C4H12N5)Cl3], respectively. A structural and supramolecular analysis was developed for all compounds using Hirshfeld surface analysis and electrostatic potential maps. The cell viability of the obtained compounds was evaluated in C2C12 (ATCCCRL-1772™) mouse muscle cells and HepG2 (ATCC HB-8065™) human liver carcinoma cells by the MTT assay to determine the potential of the compounds as new safe drugs. The results demonstrate that the compounds exhibit low cytotoxicity at doses less than 250 μg mL-1 with a cell viability greater than 80%.Universidad Santiago de CaliCoordenação de Aperfeicoamento de Pessoal de Nível SuperiorNational Council for Scientific and Technological DevelopmentCOL00067238 páginasapplication/pdfengRoyal Society of ChemistryCambridge, Inglaterrahttps://creativecommons.org/licenses/by-nc/4.0/http://creativecommons.org/licenses/by-nc/2.5/co/info:eu-repo/semantics/openAccesshttp://purl.org/coar/access_right/c_abf2Biguanide-transition metals complexes as potential drug for hyperglycemia treatmentArtículo de investigaciónhttp://purl.org/coar/resource_type/c_2df8fbb1https://purl.org/redcol/resource_type/ARThttp://purl.org/coar/version/c_970fb48d4fbd8a85info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionHiperglucemiaHyperglycemiaBiguanidasBiguanidesMetforminaMetforminhttps://id.nlm.nih.gov/mesh/D006943https://id.nlm.nih.gov/mesh/D001645https://id.nlm.nih.gov/mesh/D008687RSC. Adv.22863382285610RSC Advances445-621118-146#305190/2017-2RoR:00dxj9a45RoR:00x0ma614RoR:03swz6y49PublicationORIGINALBalcazarNorman_2020_Biguanide_Transition_Metals.pdfBalcazarNorman_2020_Biguanide_Transition_Metals.pdfArtículo de investigaciónapplication/pdf971526https://bibliotecadigital.udea.edu.co/bitstreams/196a1f72-41d7-4bd9-adb3-6c0c8643a991/download44b3aba3bfaa73fd0205fc4810c27a88MD51trueAnonymousREADLICENSElicense.txtlicense.txttext/plain; charset=utf-81748https://bibliotecadigital.udea.edu.co/bitstreams/8d93dab4-2987-4e75-8dc8-301b0ed9352c/download8a4605be74aa9ea9d79846c1fba20a33MD52falseAnonymousREADTEXTBalcazarNorman_2020_Biguanide_Transition_Metals.pdf.txtBalcazarNorman_2020_Biguanide_Transition_Metals.pdf.txtExtracted texttext/plain41102https://bibliotecadigital.udea.edu.co/bitstreams/72eec5f3-36c3-45fa-b693-9f60543fa84b/downloadb0d135122b1c45916bb643f0fedd8fc3MD53falseAnonymousREADTHUMBNAILBalcazarNorman_2020_Biguanide_Transition_Metals.pdf.jpgBalcazarNorman_2020_Biguanide_Transition_Metals.pdf.jpgGenerated Thumbnailimage/jpeg17024https://bibliotecadigital.udea.edu.co/bitstreams/794edbb9-d7ef-4413-9e55-f3b0d71aef77/download35dfd708ca9b3899bb6c5a7c364fc1afMD54falseAnonymousREAD10495/41104oai:bibliotecadigital.udea.edu.co:10495/411042025-03-27 01:31:15.462https://creativecommons.org/licenses/by-nc/4.0/open.accesshttps://bibliotecadigital.udea.edu.coRepositorio Institucional de la Universidad de Antioquiaaplicacionbibliotecadigitalbiblioteca@udea.edu.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 |
